Natural Capsules Share Price
227.70+0.72 (+0.32%)
+9.95% past 1 Year
Natural Capsules (NCL) is a respected manufacturer in the pharmaceutical industry, with a strong presence in both capsule and active pharmaceutical ingredient (API) production.
Corporate filings & documents
Announcements
Newspaper Publication for Completion of dispatch of Corrigendum Notice of Extraordinary General Meeting ("EGM").
19 hours agoNewspaper Publication for Completion of dispatch of Corrigendum Notice of Extraordinary General Meeting ("EGM").
19 hours agoWe wish to inform you that the company has today Wednesday September 02 2026 completed the dispatch of the Corrigendum to the EGM Notice to all eligible members of the Company.
1 day agoWe wish to inform you that the company has today Wednesday September 02 2026 completed the dispatch of the Corrigendum to the EGM Notice to all eligible members of the Company.
1 day ago1. Approved the Revised Price and Quantity of Equity Shares and Convertible Warrants of Preferential Issue.2. Approval of the Corrigendum Notice of Extra Ordinary General Meeting.
2 days ago1. Approved the Revised Price and Quantity of Equity Shares and Convertible Warrants of Preferential Issue.2. Approval of the Corrigendum Notice of Extra Ordinary General Meeting.
2 days agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve Pursuant to Regulation 29 and Regulation 30 read with Schedule III of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 as amended we wish to inform you that a meeting of the Board of Directors ofNatural Capsules Limited is scheduled to be held today Wednesday September 02 2026 at Shorter Notice.The meeting is being convened at shorter notice due to the urgent requirement to respond to queries raised by BSE &NSE regarding the valuation report and the consequent necessity to revise the allotment price strictly within statutorytimelines. Consent for holding the Board Meeting at shorter notice has been duly obtained from the Directors inaccordance with Section 173(3) of the Companies Act 2013 and Secretarial Standard-1 (SS-1).
2 days agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve Pursuant to Regulation 29 and Regulation 30 read with Schedule III of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 as amended we wish to inform you that a meeting of the Board of Directors ofNatural Capsules Limited is scheduled to be held today Wednesday September 02 2026 at Shorter Notice.The meeting is being convened at shorter notice due to the urgent requirement to respond to queries raised by BSE &NSE regarding the valuation report and the consequent necessity to revise the allotment price strictly within statutorytimelines. Consent for holding the Board Meeting at shorter notice has been duly obtained from the Directors inaccordance with Section 173(3) of the Companies Act 2013 and Secretarial Standard-1 (SS-1).
2 days agoCopy of Newspaper Publication (i.e. Dispatch of EGM Notice for the attention of the Equity shareholders)
2 weeks agoCopy of Newspaper Publication (i.e. Dispatch of EGM Notice for the attention of the Equity shareholders)
2 weeks agoCopy of Newspaper Advertisement i.e Notice for attention of equity shareholders of the company.
2 weeks agoCopy of Newspaper Advertisement i.e Notice for attention of equity shareholders of the company.
2 weeks agoCut-off Date (Record Date) for Extraordinary General Meeting ("EGM") is fixed on September 2nd 2026.
2 weeks agoCut-off Date (Record Date) for Extraordinary General Meeting ("EGM") is fixed on September 2nd 2026.
2 weeks agoWe are hereby submitting the Notice of the Extraordinary General Meeting (EGM) of the Company scheduled to be held on Wednesday September 09 2026 at 12:00 PM (IST) through Video Conference ("VC") or Other Audio Visual Means ("OAVM") which is also being sent by electronic mode (Emails) to the Members.
2 weeks agoWe are hereby submitting the Notice of the Extraordinary General Meeting (EGM) of the Company scheduled to be held on Wednesday September 09 2026 at 12:00 PM (IST) through Video Conference ("VC") or Other Audio Visual Means ("OAVM") which is also being sent by electronic mode (Emails) to the Members.
2 weeks agoThis is to inform you that Mr. Pramod Kasat has tendered his resignation from the position of Independent Director of Natural Biogenex Private Limited ("Material Unlisted Subsidiary") with effect from August 17 2026.
2 weeks agoThis is to inform you that Mr. Pramod Kasat has tendered his resignation from the position of Independent Director of Natural Biogenex Private Limited ("Material Unlisted Subsidiary") with effect from August 17 2026.
2 weeks agoApproved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30 2026.
2 weeks agoApproved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30 2026.
2 weeks agoWe hereby inform that the Unaudited Financial Results for the Quarter ended June 30 2026 has been published in Business Line an English Daily & Sanjevani a Kannada daily.
2 weeks agoWe hereby inform that the Unaudited Financial Results for the Quarter ended June 30 2026 has been published in Business Line an English Daily & Sanjevani a Kannada daily.
2 weeks agoWe are submitting herewith voting results & scrutinizers report of 33rd AGM of Natural Capsules Limited.
3 weeks agoWe are submitting herewith voting results & scrutinizers report of 33rd AGM of Natural Capsules Limited.
3 weeks agoPlease find enclosed herewith the copy of Investors Presentation in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30 2026.
3 weeks agoPlease find enclosed herewith the copy of Press Release made to analysts and investors in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30 2026.
3 weeks agoNatural Biogenex Private Limited ("Material Unlisted Subsidiary") at its Board Meeting held on today has appointed Mr. K. H. Honneshaiah as the new Chief Operating Officer of the Company.
3 weeks agoNatural Biogenex Private Limited ("Material Unlisted Subsidiary") at its Board Meeting held on today has appointed Mr. K. H. Honneshaiah as the new Chief Operating Officer of the Company.
3 weeks ago1. Approved the unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30 2026.2. Preferential Issue of Equity Shares and Warrants to Promoter.
3 weeks ago1. Approved the unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30 2026.2. Preferential Issue of Equity Shares and Warrants to Promoter.
3 weeks ago33rd Annual General Meeting of the Company held on Wednesday August 12 2026 at 12.10 P.M. through Video conferencing ("VC") other Audio-visual Means ("OAVM") and was concluded at 01:00 PM.
3 weeks ago33rd Annual General Meeting of the Company held on Wednesday August 12 2026 at 12.10 P.M. through Video conferencing ("VC") other Audio-visual Means ("OAVM") and was concluded at 01:00 PM.
3 weeks agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Update on board meeting 1. Evaluate proposal for raising of funds by way of issue of equity shares convertibles and / or any other eligible securities on a preferential basis subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
3 weeks agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Update on board meeting 1. Evaluate proposal for raising of funds by way of issue of equity shares convertibles and / or any other eligible securities on a preferential basis subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
3 weeks agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30th 2026.2. Any other matters with the permission of the Chairman.
1 month agoNatural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30th 2026.2. Any other matters with the permission of the Chairman.
1 month agoNatural Biogenex Private Limited ("Material Unlisted Subsidiary") at its Board Meeting held on today i.e. July 31 2026 has approved the Allotment of the Right Issue duly approved on Board Meeting dated on July 10 2026 of the Company.
1 month agoNatural Biogenex Private Limited ("Material Unlisted Subsidiary") at its Board Meeting held on today i.e. July 31 2026 has approved the Allotment of the Right Issue duly approved on Board Meeting dated on July 10 2026 of the Company.
1 month agoBoard of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July 2026 and the final majority vote was received by 08:00 PM decided not to subscribe to the Right Issue offered by its subsidiary company Natural Biogenex Private Limited.
1 month agoBoard of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July 2026 and the final majority vote was received by 08:00 PM decided not to subscribe to the Right Issue offered by its subsidiary company Natural Biogenex Private Limited.
1 month agoNewspaper Publication for Completion of Dispatch of Notice of 33rd Annual General Meeting and Annual Report for F.Y 2025-26.
1 month agoNewspaper Publication for Completion of Dispatch of Notice of 33rd Annual General Meeting and Annual Report for F.Y 2025-26.
1 month agoAnnual Report for the Financial Year 2025-26.
1 month agoAnnual Report for the Financial Year 2025-26.
1 month agoNotice of the 33rd Annual General Meeting ("AGM") of the Company scheduled to be held on Wednesday August 12 2026 at 12:00 PM (IST) through Video Conference ("VC") or Other Audio Visual Means ("OAVM")
1 month agoNotice of the 33rd Annual General Meeting ("AGM") of the Company scheduled to be held on Wednesday August 12 2026 at 12:00 PM (IST) through Video Conference ("VC") or Other Audio Visual Means ("OAVM")
1 month agoThe Record Date for 33rd Annual General Meeting is set on August 05 2026; Wednesday.
1 month agoThe Record Date for 33rd Annual General Meeting is set on August 05 2026; Wednesday.
1 month agoIntimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 - Copy of Newspaper Advertisement i.e. Notice for attention of equity shareholders of the Company.
1 month agoIntimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 - Copy of Newspaper Advertisement i.e. Notice for attention of equity shareholders of the Company.
1 month agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Jun 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Oct 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2023-07-20
Dividend
1.0
Company details
Registered office
Trident Towers 4th Floor, No. 23, 100 Feet Road Jaynagar I I Block Bengaluru Karnataka PIN: 560011 Tel No: 080- 26561562 / 1571 / 1573 / 581 Fax No: 080- 26671562 Email: [email protected] / [email protected] Internet: www.naturalcapsules.com
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
Akshay Dutta, Company Secretary & Compliance Officer
Tekkar Yashwanth Prabhu, Chairman
Laxminarayan Moondra, Whole Time Director
Sunil L Mundra, Managing Director
S G Belapure, Non Executive Independent Director
Pramod Kasat, Non Executive Independent Director
Sushil Kumar Mundra, Non Independent & Non Executive Director
Jyoti Mundra, Non Independent & Non Executive Director
Satyanarayan Mundra, Whole Time Director
Details
BSE 524654
NSE NATCAPSUQ
ISIN INE936B01015